Rights and permissions
About this article
Cite this article
Entecavir outlasts the alernatives for affordable hep B therapy. Inpharma Wkly. 1649, 3 (2008). https://doi.org/10.2165/00128413-200816490-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816490-00003